Clinuvel Pharmaceuticals（CUVL.US）股东结构 - 机构持仓、大股东与内部人士｜长桥证券

© 2026 Longbridge｜服务条款隐私政策

股东类型

公众及其他64.03%
机构投资者22.98%
个人与内部人士7.55%
私营企业5.14%
上市公司0.30%

主要股东

主要股东最新
股东
JPMorgan Chase & Co.	6.96%	350.74 万	1.40%	+71.61 万	2026/04/08
Philippe WolgenCEO, MD & Director	6.79%	342.52 万	0.03%	+0	2026/06/15
BNY Asset Management	6.65%	335.47 万	0.03%	+0	2025/11/10
Ender I , LLC	5.14%	259.08 万	0.02%	+0	2026/06/15
Vanguard Capital Management, LLC	3.25%	163.86 万	0.00%	+0	2026/07/31
Dimensional Fund Advisors LP	1.81%	91.12 万	<0.01%	+2,226.00	2026/07/31
Vanguard Investments Australia Limited	1.68%	84.94 万	<0.01%	+9.00	2026/06/30
Norges Bank Investment Management	1.10%	55.71 万	<0.01%	+0	2025/12/31
Australian Super Pty Ltd	0.42%	21.12 万	<0.01%	+0	2025/12/31
Dennis WrightChief Scientific Officer	0.40%	20.03 万	0.01%	+8,000.00	2026/06/15
Spheria Emerging Companies Limited	0.30%	15.22 万	<0.01%	+0	2025/06/30
Spheria Asset Management Pty Ltd	0.30%	15.22 万	<0.01%	+0	2025/06/30
Lachlan HayChief Operations Officer	0.30%	14.89 万	<0.01%	+5,600.00	2026/06/15
White Funds Management Pty Ltd.	0.20%	10.01 万	<0.01%	+0	2025/03/31
Macquarie Investment Management Global Limited	0.19%	9.81 万	0.03%	+1.43 万	2026/07/31
Charles Schwab Investment Management, Inc.	0.18%	8.88 万	<0.01%	+237.00	2026/07/31
State Street Investment Management	0.09%	4.46 万	<0.01%	+171.00	2026/07/31
BlackRock, Inc.	0.08%	3.85 万	<0.01%	+595.00	2026/07/31
JP Morgan Asset Management	0.03%	1.71 万	--	+1.71 万	2026/04/08
Peter VaughanChief Financial Officer	0.03%	1.48 万	0.02%	+1.13 万	2026/06/15